Joby Aviation Bets on Defense With $500 Million Resonant Sciences Deal
Joby Aviation (JOBY) shares fell 49% over six months to $4.65. Blade, a subsidiary, drove Q2 revenue to $38.6M, leading to raised full-year guidance of $115M-$125M. Joby plans to acquire Resonant Sciences for $500M, with Q3 results on November 4 to update cash burn and aircraft progress. Joby reported a $197M adjusted EBITDA loss in Q2.
How this was made
The 30-second read
Why it matters
The $500 M purchase will reduce cash reserves by roughly one‑fifth, increase loss in the near term, but may open a new revenue stream.
Market read
Primary corporate news with material financial impact; likely to move Joby's stock sharply.
What to watch
Potential synergies with Toyota JV and long‑term defense contracts may offset short‑term cash burn.
Background
Joby Aviation, previously focused on urban air mobility, is expanding into defense through the Resonant Sciences acquisition while its Blade service drives most current revenue.
Ticker impact
Joby Aviation announced a $500 million cash acquisition of Resonant Sciences, a new primary deal affecting its balance sheet and cash burn.
likely downward pressure as investors price in the cash outflow and modest near‑term earnings impact
Deal size is material, cash usage is significant relative to cash holdings, and the market has already reacted with a sharp share decline.
Market effects
Highlights growing interest in defense contracts for eVTOL firms, may boost peer valuations in aerospace/defense sector.
US aerospace and defense stocks could see modest re‑rating as investors assess defense‑related growth opportunities.
Limited to U.S. listed eVTOL and defense markets; no broad macro impact.
Counterpoint
The deal could diversify revenue and provide a stable defense cash flow, offering upside if integration succeeds.
Key entities
- CompanyJoby Aviation
U.S.-listed eVTOL operator (ticker JOBY).
- CompanyResonant Sciences
Defense business being acquired; not publicly listed.
